[{"type": "title", "data": "OB Preterm Labour (Module)"}, {"type": "category", "data": "Patient Care"}, {"type": "note", "data": "Prior to loading dose", "value": ""}, {"type": "order", "data": "Vital Signs", "value": "checked"}, {"type": "sentence", "data": "once, prior to NIFEdipine loading dose"}, {"type": "note", "data": "During loading dose therapy and for 2 hours after last loading dose", "value": ""}, {"type": "order", "data": "Vital Signs", "value": "checked"}, {"type": "sentence", "data": "During NIFEdipine loading dose therapy and for 2 hours after last NIFEdipine loading dose: assess maternal BP and heart rate prior to each dose and q15min; assess maternal respiratory rate and O2 sat q1h"}, {"type": "order", "data": "Electronic Fetal Monitoring", "value": "checked"}, {"type": "sentence", "data": "Continuous during NIFEdipine loading dose therapy and for 2 hours after last NIFEdipine loading dose"}, {"type": "note", "data": "During maintenance therapy for a maximum of 48 hours", "value": ""}, {"type": "order", "data": "Vital Signs", "value": "checked"}, {"type": "sentence", "data": "During NIFEdipine maintenance dose: maternal BP and heart rate prior to and q4h following each NIFEdipine dose for 48 hours"}, {"type": "order", "data": "Insert Saline Lock", "value": ""}, {"type": "sentence", "data": "T;N"}, {"type": "order", "data": "Intermittent Auscultation", "value": ""}, {"type": "sentence", "data": "qshift when Electronic Fetal Monitoring (EFM) is discontinued"}, {"type": "category", "data": "Diet/Nutrition"}, {"type": "order", "data": "NPO", "value": "checked"}, {"type": "sentence", "data": "Until contractions stop and loading doses of NIFEdipine complete"}, {"type": "order", "data": "Clear Fluid Diet", "value": ""}, {"type": "sentence", "data": "T;N"}, {"type": "category", "data": "Continuous Infusions"}, {"type": "order", "data": "sodium chloride 0.9% (NS) continuous infusion", "value": ""}, {"type": "sentence", "data": "order rate: 125 mL/h, IV, drug form: bag"}, {"type": "category", "data": "Medications"}, {"type": "note", "data": "All Gestational Ages", "value": ""}, {"type": "note", "data": "If less than 32 weeks and at risk for imminent birth, consider OB Magnesium Sulfate (Module)", "value": ""}, {"type": "order", "data": "NIFEdipine", "value": ""}, {"type": "sentence", "data": "10 mg, PO, q30min, PRN other (see comment), drug form: cap"}, {"type": "order", "data": "NIFEdipine long acting XL", "value": ""}, {"type": "sentence", "data": "30 mg, PO, q12h, order duration: 48 hour, drug form: tab-XL"}, {"type": "note", "data": "Alternative If Less Than 32 Weeks", "value": ""}, {"type": "order", "data": "indomethacin", "value": ""}, {"type": "sentence", "data": "100 mg, rectal, once, drug form: supp, first dose: NOW"}, {"type": "order", "data": "indomethacin", "value": ""}, {"type": "sentence", "data": "25 mg, PO, q6h, order duration: 8 doses or times, drug form: cap"}, {"type": "note", "data": "For patients between 23 and 34 weeks of gestation at risk of delivery, administer a single course of corticosteroids", "value": ""}, {"type": "order", "data": "betamethasone", "value": ""}, {"type": "sentence", "data": "12 mg, IM, q24h, order duration: 2 doses or times, drug form: inj"}, {"type": "note", "data": "If additional betamethasone dose(s) to be given as an outpatient encounter, order the OB Betamethasone Outpatient", "value": ""}, {"type": "note", "data": "ceFAZolin can be safely administered to patients with penicillin allergy, including anaphylaxis. Do NOT administer if severe delayed skin reaction to any beta-lactam (e.g. drug reaction with eosinophilia and systemic symptoms, Stevens-Johnson syndrome, toxic epidermal necrolysis)", "value": ""}, {"type": "note", "data": "Group B Strep Prophylaxis", "value": ""}, {"type": "note", "data": "Order if Group B Strep positive (positive culture, Group B Strep bacteriuria in current pregnancy, prior neonate with Group B Strep disease)", "value": ""}, {"type": "note", "data": "If Group B Strep status unknown, order only if risk factors present (less than 37 weeks of gestation, membrane rupture 18 hours or more, fever, prior neonate with Group B Strep disease)", "value": ""}, {"type": "order", "data": "penicillin G sodium", "value": ""}, {"type": "sentence", "data": "5 million_unit, IV, once"}, {"type": "note", "data": "AND", "value": ""}, {"type": "order", "data": "penicillin G sodium", "value": ""}, {"type": "sentence", "data": "2.5 million_unit, IV, q4h, order duration: 7 day"}, {"type": "order", "data": "ceFAZolin", "value": ""}, {"type": "sentence", "data": "2,000 mg, IV, once, drug form: bag"}, {"type": "note", "data": "AND", "value": ""}, {"type": "order", "data": "ceFAZolin", "value": ""}, {"type": "sentence", "data": "1,000 mg, IV, q8h, order duration: 7 day, drug form: bag"}, {"type": "note", "data": "If ceFAZolin allergic or contraindicated and if organism is susceptible to clindamycin", "value": ""}, {"type": "order", "data": "clindamycin", "value": ""}, {"type": "sentence", "data": "900 mg, IV, q8h, order duration: 7 day"}, {"type": "note", "data": "If ceFAZolin allergic or contraindicated and organism susceptibilities unknown", "value": ""}, {"type": "order", "data": "vancomycin", "value": ""}, {"type": "sentence", "data": "1,000 mg, IV, q12h, order duration: 7 day"}, {"type": "category", "data": "Laboratory"}, {"type": "order", "data": "CBC and Differential", "value": ""}, {"type": "sentence", "data": "Blood, Routine, Collection: T;N, once"}, {"type": "order", "data": "POC CBC", "value": ""}, {"type": "sentence", "data": "Whole Blood, Routine, Collection: T;N, once"}, {"type": "order", "data": "POC Hemoglobin", "value": ""}, {"type": "sentence", "data": "once, Routine"}, {"type": "order", "data": "Group and Screen", "value": ""}, {"type": "sentence", "data": "Blood, Routine, Collection: T;N, once"}, {"type": "order", "data": "POC Urinalysis Dipstick", "value": ""}, {"type": "sentence", "data": "once"}, {"type": "order", "data": "Urinalysis Macroscopic (dipstick) with Microscopic if indicated", "value": ""}, {"type": "sentence", "data": "Urine, Routine, Unit collect, Collection: T;N, once"}, {"type": "order", "data": "Urine Culture", "value": ""}, {"type": "sentence", "data": "Urine  (specify site), Routine, Unit Collect, Collection: T;N, once"}, {"type": "order", "data": "Urine Culture (if Screen Positive)", "value": ""}, {"type": "sentence", "data": "Urine, Midstream, Routine, Unit collect, Collection: T;N, once"}, {"type": "order", "data": "Group B Strep screen", "value": ""}, {"type": "sentence", "data": "Vaginal-Rectal, Routine, Collection: T;N, once"}, {"type": "order", "data": "Bacterial Vaginosis and Yeast Screen", "value": ""}, {"type": "sentence", "data": "Vagina, Routine, Collection: T;N, once"}, {"type": "order", "data": "Chlamydia/Gonorrhea Genital NAT", "value": ""}, {"type": "sentence", "data": "Cervix, Routine, Collection: T;N, once"}, {"type": "order", "data": "Treponema pallidum Antibody", "value": ""}, {"type": "sentence", "data": "Blood, Routine, Collection: T;N, once"}, {"type": "order", "data": "Fetal Fibronectin", "value": ""}, {"type": "sentence", "data": "Vagina, Routine, Collection: T;N, once"}, {"type": "order", "data": "Chlamydia/Gonorrhea/Trichomonas NAT CWH", "value": ""}, {"type": "sentence", "data": "Cervix, Routine, Collection: T;N, once"}, {"type": "note", "data": "Consider testing for syphilis if the patient:\n- Presents late to prenatal care, or first present at delivery\n- Were diagnosed with an STI in the last 10 years\n- Are living with a substance use disorder or mental health condition\n- Are unstably housed\n- Have a history of incarceration\n- Engage in sex work or survival sex\n- Have a partner who does not live with them, including a partner who lives abroad\n- Have an unexplained premature delivery prior to 37 weeks, or pregnancy loss after 20 weeks (including stillbirth)\n- You have identified to be at risk\n", "value": ""}, {"type": "order", "data": "Syphilis Screening at Delivery", "value": ""}, {"type": "sentence", "data": "Blood, Routine, Collection: T;N, once"}]
